Immunohistochemical localization of betacellulin, a new member of the EGF family, in normal human pancreas and islet tumor cells

Jun Ichiro Miyagawa, Toshiaki Hanafusa, Reiko Sasada, Koji Yamamoto, Koichi Igarashi, Katsumi Yamamori, Masaharu Seno, Hiroko Tada, Takao Nammo, Ming Li, Kazuya Yamagata, Hiromu Nakajima, Mitsuyoshi Namba, Masamichi Kuwajima, Yuji Matsuzawa

Research output: Contribution to journalArticle

52 Citations (Scopus)

Abstract

Betacellulin (BTC) purified from mouse β cell tumor (βTC-3) is a new member of the epidermal growth factor (EGF) family which can bind receptor tyrosine kinase, EGF receptor (erbB1) and erbB4. It has been demonstrated that proBTC mRNA was abundantly expressed in human pancreas tissue, and that BTC converted amylase-secreting rat acinar cell line (AR42J) into insulin- secreting cells, suggesting that BTC might be important for the growth and/or differentiation of islet cells. However, the cell type producing BTC in the pancreas has not been clarified. In this study, we examined the localization of BTC in human pancreas and islet cell tumors. Immunohistochemistry using specific antibodies to human BTC revealed that this protein was produced in a cells and duct cells, and probably in β cells in normal adult pancreas. Furthermore, strong immunoreactivity to BTC was detected in primitive duct cells of the fetal pancreas, and both insulinoma and glucagonoma cells also showed positive immunoreactivity to BTC. EGF receptor (erbB1) and erbB4 were expressed mainly in islet and duet cells, and duct cells, respectively. These results demonstrate the localization of BTC and its receptors, and suggest that BTC may be one of the factors that have physiologically important roles such as growth and differentiation of islet cells in the human pancreas.

Original languageEnglish
Pages (from-to)755-764
Number of pages10
JournalEndocrine Journal
Volume46
Issue number6
Publication statusPublished - Dec 1999

Fingerprint

Islet Cell Adenoma
Epidermal Growth Factor
Pancreas
Islets of Langerhans
Epidermal Growth Factor Receptor
Glucagonoma
Betacellulin
Insulinoma
Acinar Cells
Insulin-Secreting Cells
Amylases
Growth
Immunohistochemistry
Cell Line

Keywords

  • β-Cell
  • Betacellulin
  • Differentiation
  • Growth factor
  • Pancreas

ASJC Scopus subject areas

  • Endocrinology

Cite this

Miyagawa, J. I., Hanafusa, T., Sasada, R., Yamamoto, K., Igarashi, K., Yamamori, K., ... Matsuzawa, Y. (1999). Immunohistochemical localization of betacellulin, a new member of the EGF family, in normal human pancreas and islet tumor cells. Endocrine Journal, 46(6), 755-764.

Immunohistochemical localization of betacellulin, a new member of the EGF family, in normal human pancreas and islet tumor cells. / Miyagawa, Jun Ichiro; Hanafusa, Toshiaki; Sasada, Reiko; Yamamoto, Koji; Igarashi, Koichi; Yamamori, Katsumi; Seno, Masaharu; Tada, Hiroko; Nammo, Takao; Li, Ming; Yamagata, Kazuya; Nakajima, Hiromu; Namba, Mitsuyoshi; Kuwajima, Masamichi; Matsuzawa, Yuji.

In: Endocrine Journal, Vol. 46, No. 6, 12.1999, p. 755-764.

Research output: Contribution to journalArticle

Miyagawa, JI, Hanafusa, T, Sasada, R, Yamamoto, K, Igarashi, K, Yamamori, K, Seno, M, Tada, H, Nammo, T, Li, M, Yamagata, K, Nakajima, H, Namba, M, Kuwajima, M & Matsuzawa, Y 1999, 'Immunohistochemical localization of betacellulin, a new member of the EGF family, in normal human pancreas and islet tumor cells', Endocrine Journal, vol. 46, no. 6, pp. 755-764.
Miyagawa JI, Hanafusa T, Sasada R, Yamamoto K, Igarashi K, Yamamori K et al. Immunohistochemical localization of betacellulin, a new member of the EGF family, in normal human pancreas and islet tumor cells. Endocrine Journal. 1999 Dec;46(6):755-764.
Miyagawa, Jun Ichiro ; Hanafusa, Toshiaki ; Sasada, Reiko ; Yamamoto, Koji ; Igarashi, Koichi ; Yamamori, Katsumi ; Seno, Masaharu ; Tada, Hiroko ; Nammo, Takao ; Li, Ming ; Yamagata, Kazuya ; Nakajima, Hiromu ; Namba, Mitsuyoshi ; Kuwajima, Masamichi ; Matsuzawa, Yuji. / Immunohistochemical localization of betacellulin, a new member of the EGF family, in normal human pancreas and islet tumor cells. In: Endocrine Journal. 1999 ; Vol. 46, No. 6. pp. 755-764.
@article{0f1f1b05ef9e4859aadf5bbd045f483a,
title = "Immunohistochemical localization of betacellulin, a new member of the EGF family, in normal human pancreas and islet tumor cells",
abstract = "Betacellulin (BTC) purified from mouse β cell tumor (βTC-3) is a new member of the epidermal growth factor (EGF) family which can bind receptor tyrosine kinase, EGF receptor (erbB1) and erbB4. It has been demonstrated that proBTC mRNA was abundantly expressed in human pancreas tissue, and that BTC converted amylase-secreting rat acinar cell line (AR42J) into insulin- secreting cells, suggesting that BTC might be important for the growth and/or differentiation of islet cells. However, the cell type producing BTC in the pancreas has not been clarified. In this study, we examined the localization of BTC in human pancreas and islet cell tumors. Immunohistochemistry using specific antibodies to human BTC revealed that this protein was produced in a cells and duct cells, and probably in β cells in normal adult pancreas. Furthermore, strong immunoreactivity to BTC was detected in primitive duct cells of the fetal pancreas, and both insulinoma and glucagonoma cells also showed positive immunoreactivity to BTC. EGF receptor (erbB1) and erbB4 were expressed mainly in islet and duet cells, and duct cells, respectively. These results demonstrate the localization of BTC and its receptors, and suggest that BTC may be one of the factors that have physiologically important roles such as growth and differentiation of islet cells in the human pancreas.",
keywords = "β-Cell, Betacellulin, Differentiation, Growth factor, Pancreas",
author = "Miyagawa, {Jun Ichiro} and Toshiaki Hanafusa and Reiko Sasada and Koji Yamamoto and Koichi Igarashi and Katsumi Yamamori and Masaharu Seno and Hiroko Tada and Takao Nammo and Ming Li and Kazuya Yamagata and Hiromu Nakajima and Mitsuyoshi Namba and Masamichi Kuwajima and Yuji Matsuzawa",
year = "1999",
month = "12",
language = "English",
volume = "46",
pages = "755--764",
journal = "Endocrine Journal",
issn = "0918-8959",
publisher = "Japan Endocrine Society",
number = "6",

}

TY - JOUR

T1 - Immunohistochemical localization of betacellulin, a new member of the EGF family, in normal human pancreas and islet tumor cells

AU - Miyagawa, Jun Ichiro

AU - Hanafusa, Toshiaki

AU - Sasada, Reiko

AU - Yamamoto, Koji

AU - Igarashi, Koichi

AU - Yamamori, Katsumi

AU - Seno, Masaharu

AU - Tada, Hiroko

AU - Nammo, Takao

AU - Li, Ming

AU - Yamagata, Kazuya

AU - Nakajima, Hiromu

AU - Namba, Mitsuyoshi

AU - Kuwajima, Masamichi

AU - Matsuzawa, Yuji

PY - 1999/12

Y1 - 1999/12

N2 - Betacellulin (BTC) purified from mouse β cell tumor (βTC-3) is a new member of the epidermal growth factor (EGF) family which can bind receptor tyrosine kinase, EGF receptor (erbB1) and erbB4. It has been demonstrated that proBTC mRNA was abundantly expressed in human pancreas tissue, and that BTC converted amylase-secreting rat acinar cell line (AR42J) into insulin- secreting cells, suggesting that BTC might be important for the growth and/or differentiation of islet cells. However, the cell type producing BTC in the pancreas has not been clarified. In this study, we examined the localization of BTC in human pancreas and islet cell tumors. Immunohistochemistry using specific antibodies to human BTC revealed that this protein was produced in a cells and duct cells, and probably in β cells in normal adult pancreas. Furthermore, strong immunoreactivity to BTC was detected in primitive duct cells of the fetal pancreas, and both insulinoma and glucagonoma cells also showed positive immunoreactivity to BTC. EGF receptor (erbB1) and erbB4 were expressed mainly in islet and duet cells, and duct cells, respectively. These results demonstrate the localization of BTC and its receptors, and suggest that BTC may be one of the factors that have physiologically important roles such as growth and differentiation of islet cells in the human pancreas.

AB - Betacellulin (BTC) purified from mouse β cell tumor (βTC-3) is a new member of the epidermal growth factor (EGF) family which can bind receptor tyrosine kinase, EGF receptor (erbB1) and erbB4. It has been demonstrated that proBTC mRNA was abundantly expressed in human pancreas tissue, and that BTC converted amylase-secreting rat acinar cell line (AR42J) into insulin- secreting cells, suggesting that BTC might be important for the growth and/or differentiation of islet cells. However, the cell type producing BTC in the pancreas has not been clarified. In this study, we examined the localization of BTC in human pancreas and islet cell tumors. Immunohistochemistry using specific antibodies to human BTC revealed that this protein was produced in a cells and duct cells, and probably in β cells in normal adult pancreas. Furthermore, strong immunoreactivity to BTC was detected in primitive duct cells of the fetal pancreas, and both insulinoma and glucagonoma cells also showed positive immunoreactivity to BTC. EGF receptor (erbB1) and erbB4 were expressed mainly in islet and duet cells, and duct cells, respectively. These results demonstrate the localization of BTC and its receptors, and suggest that BTC may be one of the factors that have physiologically important roles such as growth and differentiation of islet cells in the human pancreas.

KW - β-Cell

KW - Betacellulin

KW - Differentiation

KW - Growth factor

KW - Pancreas

UR - http://www.scopus.com/inward/record.url?scp=0033388699&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033388699&partnerID=8YFLogxK

M3 - Article

C2 - 10724350

AN - SCOPUS:0033388699

VL - 46

SP - 755

EP - 764

JO - Endocrine Journal

JF - Endocrine Journal

SN - 0918-8959

IS - 6

ER -